Abstract

“3D PRINTING: A NEW AVENUE IN PHARMACEUTICALS”

*Kazi Marzuka S. and Jasvi Umme Kulsum

Abstract

3D-printing (3DP) is the art and science of printing in a new dimension using 3D printers to transform 3D computer aided designs (CAD) into life-changing products. With ‗SIPTRAM‘ the first 3D printed tablet acquiring FDA approval, has opened new avenues in pharmaceutical manufacturing. It is perched as the next technology revolution for the pharmaceutical and medical-device industries. Additive manufacturing classifies the 3DP process in namely seven categories i.e. material jetting, binder jetting, material extrusion, powder bed fusion, photopolymerisation, directed energy deposition and sheet lamination. This review objectively explores the potential growth, impact, quality assurance and regulatory problems of 3DP in pharmaceutical and medical devices industry.

Keywords: 3D-printing, computer aided designs, fused deposition modeling, stereolithography, bioprinting.